Renal Inflammatory Myofibroblastic Tumor in an Infant: Case Report with Review of Literature by Vinayak Dave, Aekta Shah, Badira Parambil, Poonam Panjwani, Sajid Qureshi, Mukta Ramadwar

Subjects: Get full text

The likelihood of being helped or harmed as a patient-centred tool to assess ALK-Inhibitors clinical impact and safety in ALK-addicted non-small cell lung cancer: A systematic revi... by Luca Mastrantoni, Giulia Giordano, Emanuele Vita, Guido Horn, Jacopo Russo, Armando Orlandi, Gennaro Daniele, Diana Giannarelli, Giampaolo Tortora, Emilio Bria

Subjects: “…ALK-inhibitors…”
Get full text

Venous thromboembolism is associated with increased all-cause mortality in ALK-positive non-small cell lung cancer by Magdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa, Katarzyna Zajda, Anna Janowicz-Żebrowska, Piotr Jaśkiewicz, Dariusz M. Kowalski, Maciej Krzakowski

Subjects: Get full text

Treatment of metastatic ALK-positive non-small cell lung cancer: indirect comparison of different ALK inhibitors using reconstructed patient data by Vera Damuzzo, Vera Damuzzo, Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, Andrea Ossato, Alessandro Inno, Andrea Messori, Andrea Messori

Subjects: Get full text

Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to ALK inhibitors in lung cancer by Sang‐Min Park, Keeok Haam, Haejeong Heo, Doyeong Kim, Min‐Ju Kim, Hyo‐Jung Jung, Seongwon Cha, Mirang Kim, Haeseung Lee

Subjects: Get full text

Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inh... by Lara Chayab, Natasha B. Leighl, Mina Tadrous, Christine M. Warren, William W. L. Wong

Subjects: “…ALK inhibitors…”
Get full text

Inflammatory myofibroblastic tumors in children: clinical characteristics and treatment outcomes with a focus on targeted therapies by Ülkü Miray Yıldırım, Rejin Kebudi, Bülent Zülfikar, Bilge Bilgiç

Subjects: Get full text

Case report: Dramatic impact of DNA next generation sequencing results using specific targeted therapies—ALK and PIK3CA by Stav Cullum, Hlu Vang, Michael Glover, Howra Alammarah, Heather Morton, Nancy Pham, Mobeen Rahman, Saad A. Khan

Subjects: “…ALK inhibitor…”
Get full text

A new ALK inhibitor overcomes resistance to first‐ and second‐generation inhibitors in NSCLC by Yue Lu, Zhenzhen Fan, Su‐Jie Zhu, Xiaoxing Huang, Zhongji Zhuang, Yunzhan Li, Zhou Deng, Lei Gao, Xuehui Hong, Ting Zhang, Li Li, Xihuan Sun, Wei Huang, Jingfang Zhang, Yan Liu, Baoding Zhang, Jie Jiang, Fu Gui, Zheng Wang, Qiyuan Li, Siyang Song, Xin Huang, Qiao Wu, Lanfen Chen, Dawang Zhou, Jianming Zhang, Cai‐Hong Yun, Liang Chen, Xianming Deng

Subjects: Get full text